Literature DB >> 12957297

Hemochromatosis and alcoholic liver disease.

Linda M Fletcher1, Lawrie W Powell.   

Abstract

The close association of excessive alcohol consumption and clinical expression of hemochromatosis has been of widespread interest for many years. In most populations of northern European extraction, more than 90% of patients with overt hemochromatosis are homozygous for the C282Y mutation in the HFE gene. Nevertheless, the strong association of heavy alcohol intake with the clinical expression of hemochromatosis remains. We (individually or in association with colleagues from our laboratories) have performed three relevant studies in which this association was explored. In the first, performed in 1975 before the cloning of the HFE gene, the frequency of clinical symptoms and signs was compared in patients with classical hemochromatosis who consumed 100 g or more of alcohol per day versus in nondrinkers or moderate drinkers who consumed less than 100 g of alcohol per day. The results showed no difference between the two groups except for features of complications of alcoholism in the first group, especially jaundice, peripheral neuritis, and hepatic failure. Twenty-five percent of those with heavy alcohol consumption showed histologic features of alcoholic liver disease (including cirrhosis) together with heavy iron overload. It was concluded that these patients had the genetic disease complicated by alcoholic liver disease. In the second study (2002), 206 subjects with classical HFE-associated hemochromatosis in whom liver biopsy had been performed were evaluated to quantify the contribution of excess alcohol consumption to the development of cirrhosis in hemochromatosis. Cirrhosis was approximately nine times more likely to develop in subjects with hemochromatosis who consumed more than 60 g of alcohol per day than in those who drank less than this amount. In the third study (2002), 371 C282Y-homozygous relatives of patients with HFE-associated hemochromatosis were assessed. Eleven subjects had cirrhosis on liver biopsy and four of these drank 60 g or more of alcohol per day. The reason why heavy alcohol consumption accentuates the clinical expression of hemochromatosis is unclear. Increased dietary iron or increased iron absorption is unlikely. The most likely explanation would seem to be the added co-factor effect of iron and alcohol, both of which cause oxidative stress, hepatic stellate cell activation, and hepatic fibrogenesis. In addition, the cumulative effects of other forms of liver injury may result when iron and alcohol are present concurrently. Clearly, the addition of dietary iron in subjects homozygous for hemochromatosis would be unwise.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957297     DOI: 10.1016/s0741-8329(03)00128-9

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  14 in total

1.  Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.

Authors:  Mohd Talha Noor; Manish Tiwari; Ravindra Kumar
Journal:  Indian J Gastroenterol       Date:  2016-02-13

Review 2.  Alcoholic liver disease.

Authors:  Helmut K Seitz; Ramon Bataller; Helena Cortez-Pinto; Bin Gao; Antoni Gual; Carolin Lackner; Philippe Mathurin; Sebastian Mueller; Gyongyi Szabo; Hidekazu Tsukamoto
Journal:  Nat Rev Dis Primers       Date:  2018-08-16       Impact factor: 52.329

3.  Addictive substances may induce a rapid neurological deterioration in fragile X-associated tremor ataxia syndrome: A report of two cases.

Authors:  Zukhrofi Muzar; Patrick E Adams; Andrea Schneider; Randi J Hagerman; Reymundo Lozano
Journal:  Intractable Rare Dis Res       Date:  2014-11

Review 4.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

5.  Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.

Authors:  Victor R Gordeuk; Sharmin F Diaz; Gladys O Onojobi; Ishmael Kasvosve; Zufan Debebe; Amanuel Edossa; Jeremy M Pantin; Shigang Xiong; Sergei Nekhai; Mehdi Nouraie; Hidekazu Tsukamoto; Robert E Taylor
Journal:  Alcohol Clin Exp Res       Date:  2008-09-06       Impact factor: 3.455

Review 6.  Role of iron in hepatic fibrosis: one piece in the puzzle.

Authors:  Marie-A Philippe; Richard-G Ruddell; Grant-A Ramm
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

7.  GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.

Authors:  James C Barton; Wen-Pin Chen; Mary J Emond; Pradyumna D Phatak; V Nathan Subramaniam; Paul C Adams; Lyle C Gurrin; Gregory J Anderson; Grant A Ramm; Lawrie W Powell; Katrina J Allen; John D Phillips; Charles J Parker; Gordon D McLaren; Christine E McLaren
Journal:  Blood Cells Mol Dis       Date:  2016-11-12       Impact factor: 3.039

8.  Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.

Authors:  Núria Aranda; Fernando E Viteri; Carme Montserrat; Victoria Arija
Journal:  Ann Hematol       Date:  2010-01-28       Impact factor: 3.673

9.  Alcohol Activates TGF-Beta but Inhibits BMP Receptor-Mediated Smad Signaling and Smad4 Binding to Hepcidin Promoter in the Liver.

Authors:  Lisa Nicole Gerjevic; Na Liu; Sizhao Lu; Duygu Dee Harrison-Findik
Journal:  Int J Hepatol       Date:  2011-10-23

Review 10.  Emerging concepts in alcoholic hepatitis.

Authors:  Phoenix Fung; Nikolaos Pyrsopoulos
Journal:  World J Hepatol       Date:  2017-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.